April 19th 2021February 11th 2021 Diversity & inclusion in Pharma Read more at: https://www.pharmexec.com/view/diversity-inclusion-in-pharma-industry-leaders-bring-conversation-to-forefront
Shorla Oncology Appoints Dennis Purcell as ChairmanMarch 29th 2022Read More Shorla Oncology Appoints Dennis Purcell as Chairman
Company Name Change: Shorla Pharma is now Shorla Oncology!March 10th 2022Read More Company Name Change: Shorla Pharma is now Shorla Oncology!
Shorla Oncology at Bio CEO & Investor conference, New York 2022February 14th 2022Read More Shorla Oncology at Bio CEO & Investor conference, New York 2022
Shorla Oncology at Euronext IPO ready programme, Dublin 2022February 14th 2022Read More Shorla Oncology at Euronext IPO ready programme, Dublin 2022
3 Keys To A Successful Biotech LaunchFebruary 1st 2022Read More 3 Keys To A Successful Biotech Launch
Shorla: making women’s and children’s cancer drugs more accessibleDecember 22nd 2021Read More Shorla: making women’s and children’s cancer drugs more accessible
Shorla Oncology at ASH, Atlanta, Georgia 2021December 2nd 2021Read More Shorla Oncology at ASH, Atlanta, Georgia 2021
CEO Sharon Cunningham met with Minister Robert Troy at Enterprise Ireland’s trade visit in BostonNovember 4th 2021Read More CEO Sharon Cunningham met with Minister Robert Troy at Enterprise Ireland’s trade visit in Boston
Shorla Oncology at CPhI Worldwide in MilanNovember 1st 2021Read More Shorla Oncology at CPhI Worldwide in Milan
